Showing results (2711-2720 of 8,257) with videos related to
Sort By:
Pageof 826
Haematologica|June 22, 2001
Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloyd leukemiaG Meloni, S Capria, M Vignetti, et al.Haematologica|June 22, 2001
Anti-CD20 antibody (rituximab) administration in patients with late occurring lymphomas after solid organ transplantG Dotti, A Rambaldi, R Fiocchi, et al.Haematologica|February 27, 2001
Cellular prion protein is expressed on peripheral blood mononuclear cells but not platelets of normal and scrapie-infected sheepL M Herrmann, W C Davis, D P Knowles, et al.Haematologica|February 27, 2001
In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretionF Rossi, E Rossi, F I Pareti, et al.Haematologica|November 5, 2002
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcomeDonatella Raspadori, Daniela Damiani, Mariagrazia Michieli, et al.Haematologica|November 5, 2002
Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myelomaElisabetta Novella, Ilaria Giaretta, Francesca Elice, et al.Haematologica|November 5, 2002
Modification of actin, myosin and tubulin distribution during cytoplasmic granule movements associated with platelet adhesionDoris Cerecedo, Roberto Stock, Sirenia González, et al.Haematologica|November 5, 2002
Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulationDolors Tàssies, Carolina Freire, Josefina Pijoan, et al.Haematologica|November 5, 2002
Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myelomaFortunato Morabito, Massimo Martino, Caterina Stelitano, et al.Haematologica|November 5, 2002
Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patientsYves BeguinPageof 826